Johnson & Johnson

NYSE:JNJ  
159.37
+2.28 (+1.45%)
4:24:59 PM EDT: $159.38 +0.01 (+0.01%)
Products

Johnson & Johnson Statement On FDA Approval Of Shelf Life Extension For Company's Covid-19 Vaccine

Published: 06/10/2021 15:07 GMT
Johnson & Johnson (JNJ) - Johnson & Johnson Statement on FDA Approval of Shelf Life Extension for Company's Covid-19 Vaccine.
J&j - U.S. FDA Has Authorized an Extension of Shelf Life for Johnson & Johnson Single-shot Covid-19 Vaccine From 3 Months to 4.5 Months.
Further Company Coverage: Jnjn ((reuters.
Briefs@thomsonreuters.
Com;)).